Vectorite Biomedical (Taiwan)

Recent papers from Vectorite Biomedical (Taiwan)

1. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell LinesJournal of Immunology Research · 2018
2. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cellsOncotarget · 2017
3. Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1 carcinoma cell modelJournal of Cancer Metastasis and Treatment · 2015
4. Ex vivo development, expansion and in vivoanalysis of a novel lineage of dendritic cells from hematopoietic stem cellsJournal of Immune Based Therapies and Vaccines · 2010
5. Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applicationsJournal of Hematology & Oncology · 2009
6. Lentiviral calnexin‐modified dendritic cells promote expansion of high‐avidity effector T cells with central memory phenotypeImmunology · 2009
7. Diverse T‐cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta‐like‐1‐modified mouse stromal cellsImmunology · 2008